A sixteen-week, double-blind, double-dummy, randomized, parallel-group, multicenter, active controlled study to assess the efficacy and safety of fluvastatin 80 mg slow release (SR) tablet compared to fluvastatin 40 mg immediate release capsule both once daily at bedtime in patients with mixed dyslipidemia or primary hypercholesterolemia

Authors
Category Primary study
Year 2006
Multicenter, double‐blind, double‐dummy, randomized, parallel group, active control study of fluvastatin 80mg slow release (SR) QD versus fluvastatin 40mg immediate release (IR) QD in patients with mixed dyslipidemia and primary hypercholesterolemia. All the eligible patients were assigned to a 4‐week placebo/dietary lead‐in period followed by a 12‐week active treatment phase after randomization at visit 2 (Week 0) to one of two double‐blind treatment groups in a 1:1 ratio.
Epistemonikos ID: 27f53c6b7bb43c0458e4fe8a69584ad6a8ffcecf
First added on: Aug 21, 2024